Found 24 articles for: "Micrographic"
Increased Postoperative Risks After Mohs Surgery in Patients With Hypothyroidism: A Cohort Study
June 2026 | Volume 25 | Issue 6 | Editorials | e58 | Copyright © June 2026
Perioperative Use of Angiotensin Inhibitors and Their Complications in Mohs Surgery: A Retrospective Cohort Study
June 2026 | Volume 25 | Issue 6 | Features | e51 | Copyright © June 2026
Minimum Margins After Positive Mohs Surgery Stages Correlate With Histologic Facing Loss
May 2026 | Volume 25 | Issue 5 | Features | 477 | Copyright © May 2026
Chronic Kidney Disease and Postoperative Complications Following Mohs Surgery: A Retrospective Cohort Study
May 2026 | Volume 25 | Issue 5 | Editorials | 486 | Copyright © May 2026
Mohs Micrographic Surgery in Female Genital Cancers: A Systematic Review
November 2025 | Volume 24 | Issue 11 | Original Article | 1080 | Copyright © November 2025
Background: Mohs micrographic surgery (MMS) has shown promising efficacy in female genital cancers, including Extramammary Paget’s disease (EMPD), dermatofibrosarcoma protu...
Read MoreMedical and Surgical Management of Multifocal Superficial Basal Cell Carcinoma
May 2025 | Volume 24 | Issue 5 | Original Article | 483 | Copyright © May 2025
Background: Multifocal superficial basal cell carcinoma (sBCC) is a subtype of BCC characterized by subclinical extension of noncontiguous tumor islands and high recurrence rates...
Read MoreEndocrine Mucin Producing Sweat Gland Carcinoma Treated With Mohs Micrographic Surgery: A Systematic Review
May 2025 | Volume 24 | Issue 5 | Original Article | 498 | Copyright © May 2025
Background: Endocrine Mucin Producing Sweat Gland Carcinoma (EMPSGC) is a low-grade, cutaneous adnexal neoplasm. It is believed to have a potential for local recurrence as well a...
Read MoreEvaluating Postoperative Outcomes of Mohs Surgery in the Elderly: A Retrospective Review of Large Repairs
May 2025 | Volume 24 | Issue 5 | Features | 537 | Copyright © May 2025
Background: As the geriatric population, defined by the National Institute on Aging as 65 years and older, continues to grow exponentially, understanding how age impacts the trea...
Read MoreSurgical Outcomes of Cylindrocarcinoma Treated With Mohs Micrographic Surgery and Excision: A Systematic Review
May 2025 | Volume 24 | Issue 5 | Original Article | 444 | Copyright © May 2025
Background: Cylindromas are benign adnexal tumors often associated with conditions such as Brooke-Spiegler Syndrome and familial cylindromatosis. Cylindromas can undergo malignan...
Read MoreNeoadjuvant Sonidegib for the Management of Locally Advanced Basal Cell Carcinoma: A Case Report
March 2025 | Volume 24 | Issue 3 | Case Reports | 329 | Copyright © March 2025
Neoadjuvant Hedgehog Pathway Inhibitor (HPI) therapy, utilizing sonidegib and vismodegib, has shown great potential in managing locally advanced basal cell carcinoma (laBCC). While effective, the...
Read MoreUse of Bovine Xenografts for Nasal Defects After Mohs Micrographic Surgery
January 2025 | Volume 24 | Issue 1 | Features | 96 | Copyright © January 2025
Background: Nasal defects after skin cancer excision can often be healed by second intention in certain circumstances.Objective: We aim to demonstra...
Read MoreMohs Micrographic Surgery for the Treatment of Lentigo Maligna and Lentigo Maligna Melanoma: An Outcomes Study
December 2024 | Volume 23 | Issue 12 | Original Article | 1094 | Copyright © December 2024
Background: Lentigo maligna (LM), a type of melanoma in situ (MIS), usually develops on sun-damaged skin in the elderly. If left untreated, it may advance to the point of dermal ...
Read MoreDiversifying the Mohs Workforce: Understanding Barriers of Applicants to Mohs Micrographic Surgery Fellowship
May 2023 | Volume 22 | Issue 5 | Original Article | 471 | Copyright © May 2023
Background: The population of the United States is becoming increasingly diverse, yet dermatology, especially Mohs micrographic surgery (MMS), lags behind.Ob...
Read MoreAssessment and Evaluation of Online Content Available on Micrographic Surgery and Dermatologic Oncology Fellowship Websites
May 2023 | Volume 22 | Issue 5 | Features | 521 | Copyright © May 2023
Comparing Histological Preparation and Tumor Debulking Techniques in Mohs Micrographic Surgery: A Cross-Sectional Survey
May 2023 | Volume 22 | Issue 5 | Features | 514 | Copyright © May 2023
Timeline: The Evolution of Fellowship Training in Micrographic Surgery and Dermatologic Oncology
August 2022 | Volume 21 | Issue 8 | Original Article | 861 | Copyright © August 2022
The Accreditation Council for Graduate Medical Education (ACGME) granted accreditation to the first 5 Procedural Dermatology Fellowship Training Programs in 2004.
The name of the training ...
Read MoreMohs Micrographic Surgery in Skin of Color
May 2022 | Volume 21 | Issue 5 | Features | 536 | Copyright © May 2022
The United States population is becoming increasingly diverse. Data show increased utilization of Mohs micrographic surgery (MMS) in people of color. Though the incidence of skin cancer in skin of col...
Read MoreOpioid Prescriptions and Pain-Related Patient-Initiated Communication After Mohs Micrographic Surgery: A Retrospective Cohort Study
May 2022 | Volume 21 | Issue 5 | Editorials | 551 | Copyright © May 2022
Background: There is a wide variety in utilization of opioids during Mohs Micrographic Surgery (MMS) despite evidence that a multimodality approach may be more beneficial.
Incomplete Staining Artifact: A Confounding Frozen Section Pathology Artifact Encountered During Mohs Micrographic Surgery
May 2022 | Volume 21 | Issue 5 | Features | 544 | Copyright © May 2022
The intent of this brief communication is to describe a unique incomplete staining frozen section pathology artifact encountered during Mohs Micrographic Surgery. At the authors’ institution, an...
Read MoreA Rare Presentation of Dermatofibrosarcoma Protuberans of the Scalp Treated with "Slow-Mohs" Micrographic Surgery
May 2022 | Volume 21 | Issue 5 | Case Reports | 534 | Copyright © May 2022
Dermatofibrosarcoma protuberans (DFSP) is a rare, fibrohistiocytic tumor with intermediate malignancy.1 While these tumors are slow-growing and only metastasize in 6% of cases,2 ...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
